Literature DB >> 27272317

Process and impact of an advance care planning intervention evaluated by bereaved surrogate decision-makers of dialysis patients.

Mi-Kyung Song1, Maureen Metzger2, Sandra E Ward3.   

Abstract

BACKGROUND: Few studies have examined the process and impact of an advance care planning intervention experienced by surrogate decision-makers of dialysis patients. AIM: To explore the perspectives of the bereaved surrogates of dialysis patients on the process and impact of an advance care planning intervention and to compare the perceived impacts of the intervention between African Americans and Whites.
DESIGN: Qualitative interviews and thematic analysis. SETTING/PARTICIPANTS: 24 bereaved surrogates of patients from outpatient dialysis centers were interviewed. Both patients and surrogates had been participants in a larger efficacy study and had received an advance care planning intervention, SPIRIT (Sharing Patient's Illness Representations to Increase Trust).
RESULTS: Two themes related to the process of SPIRIT were as follows: (1) SPIRIT provided a welcome opportunity to think about and discuss topics that had been avoided and (2) SPIRIT helped patients and surrogates to share their feelings. Four themes of the SPIRIT's impact were as follows: (1) SPIRIT was an eye-opening experience, acquiring knowledge and understanding of the patient's illness and end-of-life care, (2) SPIRIT helped strengthen relationships between patients and surrogates, (3) SPIRIT helped surrogates feel prepared during the time leading up to end-of-life decision-making, and (4) SPIRIT helped surrogates have peace of mind during and after actual end-of-life decision-making. Themes related to SPIRIT's impact on feeling prepared for end-of-life decision-making and the actual decision-making experience more frequently occurred in African Americans than in Whites.
CONCLUSION: Our data may help explain the beneficial effects of SPIRIT on surrogates, but future trials should include data on control surrogates' perspectives.

Entities:  

Keywords:  Advance care planning; bereavement; dialysis; race; surrogate decision-maker

Mesh:

Year:  2016        PMID: 27272317     DOI: 10.1177/0269216316652012

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  5 in total

1.  SPIRIT advance care planning intervention in early stage dementias: An NIH stage I behavioral intervention development trial.

Authors:  Mi-Kyung Song; Sandra E Ward; Kenneth Hepburn; Sudeshna Paul; Raj C Shah; Darby J Morhardt
Journal:  Contemp Clin Trials       Date:  2018-06-02       Impact factor: 2.226

2.  "End-of-Life Care? I'm not Going to Worry About That Yet." Health Literacy Gaps and End-of-Life Planning Among Elderly Dialysis Patients.

Authors:  Keren Ladin; Katie Buttafarro; Emily Hahn; Susan Koch-Weser; Daniel E Weiner
Journal:  Gerontologist       Date:  2018-03-19

3.  Advance care planning in amyotrophic lateral sclerosis (ALS): study protocol for a qualitative longitudinal study with persons with ALS and their family carers.

Authors:  Isabel Vandenbogaerde; Rose Miranda; Jan L De Bleecker; Emma Carduff; Agnes van der Heide; Lieve Van den Block; Luc Deliens; Aline De Vleminck
Journal:  BMJ Open       Date:  2022-05-12       Impact factor: 3.006

4.  Top Ten Tips Palliative Care Clinicians Should Know About Solid Organ Transplantation.

Authors:  Naoka Murakami; Nathan D Baggett; Margaret L Schwarze; Keren Ladin; Andrew M Courtwright; Hilary J Goldberg; Eric P Nolley; Nelia Jain; Michael Landzberg; Kirsten Wentlandt; Jennifer C Lai; Myrick C Shinall; Nneka N Ufere; Christopher A Jones; Joshua R Lakin
Journal:  J Palliat Med       Date:  2022-03-11       Impact factor: 2.947

5.  Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis.

Authors:  Marcus Sellars; Josephine M Clayton; Karen M Detering; Allison Tong; David Power; Rachael L Morton
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.